Microbial protein company MicroHarvest has secured €8.5 million in a Series A funding round led by Astanor Ventures and Happiness Capital.
The funding will support the commercialisation of MicroHarvest’s single-cell protein production process.
The Hamburg-based start-up’s proprietary technology enables the production of protein using bacteria at a speed and efficiency that is said to ‘greatly exceed’ existing approaches.
MicroHarvest will use the funding to grow its R&D team, construct a pilot plant in Lisbon and accelerate towards commercial-scale production. After a successful acceptance trial this year, an at-scale production trial will yield product for further application trials, with the aim to enter the market in 2023.
Possible applications of the company’s protein are numerous, ranging from animal feed to human food.
Alongside Astanor and Happiness Capital, Faber and existing investor FoodLabs also joined the round.
“MicroHarvest’s approach is by far the easiest and most scalable way to produce sustainable protein that we have come across, with applications along the whole protein value chain. We’re impressed with what the MicroHarvest team has achieved in such a short time,” said Christian Guba, investor at FoodLabs.
© FoodBev Media Ltd 2022
World Beverage Innovation Awards – NOW OPEN FOR ENTRIES!
The awards celebrate excellence and innovation across the global beverage industry. Don’t miss out on having your innovations recognised on a global scale.
Deadline for entries 23 July – enter now!
Don’t get left behind
Start your free Foodbev magazine trial today and join thousands of fellow industry professionals in receiving food and drink trends direct to our business.
Click here to start your free trial
Your privacy We use small files known as ‘cookies’ to enhance your experience of the FoodBev website and analyse site-traffic. Read about how we use cookies or how you may control them in our updated privacy policy and cookie policy. If you continue to use this site, you consent to our use of cookies. Click the ‘OKAY‘ button at the top right of this panel to accept or click here for more information.